Tag Archive for: Funding

DaltonTx awarded grant to accelerate AI-powered tuberculosis drug discovery

Funding from the Gates Foundation supports development of open-access AI models, workflows and datasets to help researchers identify new tuberculosis (TB) targets for faster and more cost-effective drug discovery Project will analyse hundreds of essential TB proteins at proteome scale, demonstrating Dalton’s ability to tackle complex scientific challenges Collaboration with Ersilia will make findings accessible […]

Breye Therapeutics raises €67.5 million in over-subscribed Series A financing

Co-led by new investor Mission BioCapital and existing investor Novo Holdings, with additional investment from existing syndicate member Sound Bioventures, and new investors the Ljungström family office, Innovestor Life Science, EIFO, Catalyze Capital, Modi Ventures, and Pappas Capital Company will now advance danegaptide, a pioneering, first-in-class oral treatment for Non-Proliferative Diabetic Retinopathy (NPDR), into a […]

xeltis

Xeltis raises an additional €20.5m of funding to advance aXess™ toward FDA approval and US commercial launch

New investor Horizon 3 Healthcare led the round, which was supported by the European Innovation Council, Invest-NL, VI Partners, EQT Life Sciences, DaVita and other current shareholders Builds on the €50m secured in 2025 and supports Xeltis’ next phase of clinical, regulatory and commercial execution Additional €20.5m provides the runway to finalize the ongoing US […]

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe

The Novo Nordisk Foundation has allocated up to DKK 5.5 billion (EUR 736 million) to BioInnovation Institute (BII), a leading institute for life science and deep tech innovation in Copenhagen. The funding will enable BII to expand its activities into new strategic areas and geographies, and support even more entrepreneurs and start-up-companies, thereby strengthening innovation […]

Optimum Strategic Communications to Host 17th Annual Healthcare Investor Conference

How can companies with promising science secure the capital they need to develop drugs What does pharma need to fill their pipelines as they look to negotiate looming patent cliffs London, UK, 7 October 2025: Optimum Strategic Communications (Optimum), the specialist life sciences communications consultancy, will be hosting its 17th Annual Healthcare Investor Conference on Thursday 9 October […]

© Optimum Strategic Communications.